| US3124505A (en)* | | 1964-03-10 | | Aerosol concentrates containing a sta- |
| US3155573A (en)* | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| US3076745A (en)* | 1958-11-17 | 1963-02-05 | Poultry Service And Res Corp | Antibiotic method for promoting poultry growth |
| US3079299A (en)* | 1959-11-16 | 1963-02-26 | Gen Aerosol Corp | Self-propelling medicinal ointment composition containing polyethylene and method ofapplication |
| US3088874A (en)* | 1960-05-23 | 1963-05-07 | Union Carbide Corp | Powder aerosol |
| DE1170909B (en)* | 1961-02-17 | 1964-05-27 | Specialties Dev Corp | Self-propelling mixture |
| US3135658A (en)* | 1961-10-10 | 1964-06-02 | Merck & Co Inc | Non-aqueous oleaginous aerosol foam therapy of bovine mastitis |
| US3095355A (en)* | 1961-10-12 | 1963-06-25 | Revlon | Aerosol composition |
| GB1013386A (en)* | 1962-05-01 | | | |
| BE632504A (en)* | 1962-05-24 | | | |
| US3169095A (en)* | 1962-10-30 | 1965-02-09 | Rexall Drug Chemical | Self-propelling powder-dispensing compositions |
| NL289785A (en)* | 1962-11-29 | | | |
| US3345295A (en)* | 1963-02-13 | 1967-10-03 | Shulton Inc | Copper cleaning compositions |
| US3304230A (en)* | 1963-02-18 | 1967-02-14 | Revlon | Liquid aerosol propellant solutions of fatty acid salts of physiologically active amines |
| US3446892A (en)* | 1963-09-18 | 1969-05-27 | Whitmire Research Lab Inc | Immobilizing insects by sudden reduction of body temperature |
| US3260408A (en)* | 1964-04-08 | 1966-07-12 | Bell & Howell Co | Method and means of dispersing particulate material in a stream of carrier fluid |
| US3282791A (en)* | 1965-08-17 | 1966-11-01 | Merck & Co Inc | Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate |
| US3968203A (en)* | 1965-10-01 | 1976-07-06 | Jerome G. Spitzer | Aerosol astringent composition |
| US3402665A (en)* | 1966-08-15 | 1968-09-24 | Aeroprojects Inc | Nonpyrotechnic disseminator |
| US4027007A (en)* | 1970-12-09 | 1977-05-31 | Colgate-Palmolive Company | Antiperspirants formulated with borax |
| GB1429184A (en)* | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
| US4411883A (en)* | 1973-02-05 | 1983-10-25 | Colgate-Palmolive Company | Antiperspirant |
| US3923971A (en)* | 1973-09-13 | 1975-12-02 | Alexandre Seilinger | Antiperspirant and deodorant composition containing lamellar substances |
| US4010252A (en)* | 1974-12-19 | 1977-03-01 | Colgate-Palmolive Company | Antimicrobial compositions |
| US4192766A (en)* | 1975-04-25 | 1980-03-11 | United Chemical Corporation | Composition for decreasing water resistance to movement |
| IL51314A (en)* | 1976-01-30 | 1980-03-31 | Fisons Ltd | Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it |
| US4147766A (en)* | 1976-06-09 | 1979-04-03 | Armour Pharmaceutical Company | Macrospherical particles of anti-perspirants |
| AU522792B2 (en)* | 1977-07-19 | 1982-06-24 | Fisons Plc | Pressure pack formulation |
| DE2804931A1 (en)* | 1978-02-06 | 1979-08-16 | Fresenius Chem Pharm Ind | METAL SULFADIAZINE IN FINE PARTICULAR FORM |
| JPS5529524A (en)* | 1978-08-21 | 1980-03-01 | Toyo Aerosol Kogyo Kk | Powdery aerosol composition |
| US4352789A (en)* | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
| CA1178889A (en)* | 1980-08-28 | 1984-12-04 | Kenneth S. Su | Intranasal formulation |
| JPS59163313A (en)* | 1983-03-09 | 1984-09-14 | Teijin Ltd | Peptide hormone composition for nasal administration |
| DE3326089A1 (en)* | 1983-07-20 | 1985-02-07 | Gödecke AG, 1000 Berlin | INHALATION-INTENDED PHARMACEUTICAL FORM OF CALCIUM ANTAGONISTS |
| ZA852884B (en)* | 1984-04-25 | 1986-11-26 | Lilly Co Eli | Sustained release intranasal formulation and method of use thereof |
| US4581225A (en)* | 1984-04-25 | 1986-04-08 | Eli Lilly And Company | Sustained release intranasal formulation and method of use thereof |
| US5766573A (en)* | 1988-12-06 | 1998-06-16 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5225183A (en)* | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
| JPH05508616A (en)* | 1989-02-23 | 1993-12-02 | ローヌー プーラン ローラー インターナショナル（ホウルディングス）インコーポレイテッド | therapeutic aerosol |
| GB8921222D0 (en)* | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
| US5439670A (en)* | 1989-11-28 | 1995-08-08 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| DE4003270A1 (en)* | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS |
| MX9203481A (en) | 1990-10-18 | 1992-07-01 | Minnesota Mining & Mfg | FORMULATIONS. |
| HU205249B (en)* | 1990-11-09 | 1992-04-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing suspensive aerosole composition |
| RU2054180C1 (en)* | 1991-08-21 | 1996-02-10 | Жирнов Олег Петрович (н/п) | Method and aerosol for treating respiratory virus infections |
| US5674471A (en)* | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
| IL104068A (en)* | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
| US5658549A (en)* | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
| US5744123A (en)* | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US5736124A (en)* | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| ATE128350T1 (en)* | 1991-12-12 | 1995-10-15 | Glaxo Group Ltd | PHARMACEUTICAL AEROSOL FORMULATION. |
| US5916540A (en) | 1994-10-24 | 1999-06-29 | Glaxo Group Limited | Aerosol formulations containing P134A and/or P227 and particulate medicament |
| US5653962A (en)* | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| CA2125666C (en)* | 1991-12-12 | 2002-07-16 | Rachel Ann Akehurst | Medicaments |
| CA2126244C (en) | 1991-12-18 | 2000-09-26 | Robert K. Schultz | Suspension aerosol formulations |
| US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US5756071A (en)* | 1992-06-03 | 1998-05-26 | Arrowdean Limited | Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier |
| US5368842A (en)* | 1992-10-29 | 1994-11-29 | The Gillette Company | High efficacy aerosol antiperspirant composition |
| IS1796B (en)* | 1993-06-24 | 2001-12-31 | Ab Astra | Inhaled polypeptide formulation composition which also contains an enhancer compound |
| US5747445A (en)* | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
| US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
| US20010003739A1 (en)* | 1993-06-24 | 2001-06-14 | Astrazeneca Ab | Systemic administration of a therapeutic preparation |
| US6794357B1 (en) | 1993-06-24 | 2004-09-21 | Astrazeneca Ab | Compositions for inhalation |
| US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
| US6165976A (en) | 1994-06-23 | 2000-12-26 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| MY131733A (en) | 1994-12-22 | 2007-08-30 | Astra Ab | Aerosol drug formulations |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| HU218940B (en) | 1994-12-22 | 2001-01-29 | Astra Aktiebolag | Paratiroid Hormone (PHT), a pharmaceutical composition for inhalation, a method for preparing, administering an inhaler device, and an inhalation device containing it |
| SE9404468D0 (en)* | 1994-12-22 | 1994-12-22 | Astra Ab | Powder formulations |
| US6054488A (en)* | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
| GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
| JP2001511160A (en) | 1997-02-05 | 2001-08-07 | ヤゴ リサーチ アクチェンゲゼルシャフト | Aerosol formulation for medical use |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
| US6946117B1 (en) | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| US20010006939A1 (en)* | 1997-10-03 | 2001-07-05 | Ralph W. Niven | Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| US6451285B2 (en)* | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| ES2234266T3 (en) | 1998-07-24 | 2005-06-16 | Jago Research Ag | MEDICAL FORMULATIONS FOR AEROSOLS. |
| DK1102579T3 (en) | 1998-08-04 | 2003-07-14 | Jago Res Ag | Medical aerosol formulations |
| US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| MXPA02001323A (en) | 2000-05-10 | 2004-07-16 | Alliance Pharma | Phospholipid-based powders for drug delivery. |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| ATE508735T1 (en) | 2001-12-19 | 2011-05-15 | Novartis Ag | PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES |
| US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
| EP1949891A1 (en) | 2004-10-12 | 2008-07-30 | Generics (UK) Limited | Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
| CA2581999C (en)* | 2004-10-12 | 2013-04-23 | Generics (Uk) Limited | Preparation of suspension aerosol formulations |
| DK2594272T3 (en) | 2005-05-18 | 2018-09-03 | Horizon Orphan Llc | Aerosolized fluoroquinolones and their applications |
| US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| US8367734B1 (en) | 2005-08-11 | 2013-02-05 | Amphastar Pharmaceuticals Inc. | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
| US20070286814A1 (en)* | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
| GB0614621D0 (en) | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
| GB0620700D0 (en) | 2006-10-19 | 2006-11-29 | 3M Innovative Properties Co | Metered dose valves and dispensers |
| MX2009008582A (en) | 2007-02-11 | 2009-10-30 | Map Pharmaceuticals Inc | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile. |
| KR20160150110A (en) | 2008-10-07 | 2016-12-28 | 랩터 파마슈티컬스 인코포레이티드 | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
| LT2473170T (en) | 2009-09-04 | 2019-10-10 | Horizon Orphan Llc | USE OF AEROSOLIZED LEVOFLOXACIN FOR THE TREATMENT OF Cystic Fibrosis |
| WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| GB201118188D0 (en) | 2011-10-21 | 2011-12-07 | 3M Innovative Properties Co | Manufacture of medicinal aerosol canisters |
| GB201210580D0 (en) | 2012-06-14 | 2012-08-01 | 3M Innovative Properties Co | Metered dose dispensing valve |
| GB201221063D0 (en) | 2012-11-23 | 2013-01-09 | 3M Innovative Properties Co | Metered dose dispensing valve |
| US20150044288A1 (en) | 2013-07-31 | 2015-02-12 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
| NZ722927A (en) | 2014-01-10 | 2022-07-29 | Avalyn Pharma Inc | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| GB2604314A (en) | 2017-09-22 | 2022-09-07 | Nerudia Ltd | Device, system and method |
| WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
| WO2023028364A1 (en) | 2021-08-27 | 2023-03-02 | Sepelo Therapeutics, Llc | Targeted compositions and uses therof |